GlassScriptPhysician profile
Merritt L Baumgartner
NPI 1538319041
$2,444.63
in general payments reported to CMS, 2019-2025
29 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $336 · 2022: $644 · 2023: $444 · 2024: $589 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $326.60 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $275.03 | 2021-2023 | |
| Daiichi Sankyo INC. | $218.13 | 2021-2025 | Injectafer |
| Hologic Sales and Service, LLC | $208.10 | 2022-2025 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Shield Therapeutics INC | $202.54 | 2023-2024 | Accrufer |
| Sumitomo Pharma America, INC. | $162.43 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $143.75 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.44 | 2021-2022 | |
| Pfizer INC. | $88.69 | 2022-2024 | |
| Agile Therapeutics, INC. | $74.73 | 2021-2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $72.23 | 2021-2025 | |
| Exeltis, USA INC. | $69.57 | 2023-2025 | Slynd |
| Aspira Women'S Health INC | $55.99 | 2022 | |
| Mayne Pharma Commercial LLC | $51.60 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $43.36 | 2024 | Exparel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $39.05 | 2021-2022 | |
| Organon LLC | $34.71 | 2024 | |
| Medtronic, INC. | $33.90 | 2024-2025 | Interstim, Truclear |
| Coopersurgical, INC. | $33.64 | 2022-2023 | Paragard T 380a |
| Millicent US INC | $32.23 | 2025 | Intrarosa, Femring, Femlyv |
| Scynexis, INC. | $30.85 | 2022 | |
| Mylan Pharmaceuticals INC. | $26.08 | 2021 | |
| Optumhealth Care Solutions, LLC | $22.71 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Davol INC. | $22.58 | 2023 | Arista Ah Flexitip |
| Therapeuticsmd, INC. | $15.70 | 2022 | |
| Merck Sharp & Dohme LLC | $15.30 | 2022 | |
| Hologic INC | $13.41 | 2021 | |
| Evofem Biosciences, INC. | $12.21 | 2021 | |
| Avion Pharmaceuticals | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merritt Baumgartner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.